Loading…
Employees: 1,370
Size PCC Rokita Spolka Akcyjna (PCR.WA) is a Poland Materials company (Chemicals: Specialty) with a market value of $327M, the 77th largest of 83 Poland companies the cockpit tracks. Shares closed at PLN 63.20 on 6 Nov 2026.
Performance Over six months the shares fell 6.9%, against -25.0% for the median peer and +14.3% for the Poland market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue fell 6.2% over the last twelve months (peer median +8.3%); the operating margin is 3.5% (peer median 1.7%).
Valuation It trades at 10.2× forward earnings against a peer median of 12.7× (cheapest of 9).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 7.0 points below its cost of capital (9.8% WACC).
Next results Next results expected around 10 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | PLN 1.79B | PLN 1.80B | PLN 1.95B | PLN 2.39B | PLN 3.14B |
| Revenue growth | — | -8% | -18% | -24% | — |
| Gross profit | PLN 342M | PLN 326M | PLN 391M | PLN 583M | PLN 1.15B |
| EBITDA | PLN 213M | PLN 188M | PLN 278M | PLN 459M | PLN 993M |
| Net income | PLN 133M | PLN 61.5M | PLN 143M | PLN 268M | PLN 675M |
| Free cash flow | PLN 134M | PLN 119M | PLN 145M | PLN 265M | PLN 535M |
| Capital expenditure | PLN 142M | PLN 152M | PLN 129M | PLN 216M | PLN 229M |
| Total debt | PLN 531M | PLN 545M | PLN 640M | PLN 599M | PLN 643M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PCR.WA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -5.5% | -15.5% | 2nd highest of 21 |
| 6-month return | -6.9% | -25.0% | 5th highest of 21 |
| Distance from 52-week high | -15.1% | -47.2% | highest of 21 |
| Revenue growth (TTM) | -6.2% | +8.3% | 3rd lowest of 21 |
| Operating margin | 3.5% | 1.7% | 9th highest of 21 |
| Forward P/E | 10.2× | 12.7× | cheapest of 9 |
| Growth the price implies (Req g, 7 yrs) | 16.1% | 17.4% | 3rd least demanding of 6 |
| Growth delivered (Del g) | +4.1% | +9.1% | 2nd lowest of 6 |
| Hurdle (Req g minus delivered) | +12.0 pp | +6.8 pp | 3rd most demanding of 6 |
| ROIC minus cost of capital | -7.0 pp | -5.1 pp | 9th lowest of 20 |
| EV / EBITDA | 8.0× | 8.9× | 4th cheapest of 9 |
| Net debt / EBITDA | 2.0× | 3.2× | 5th least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| PCC Rokita Spolka Akcyjna PCR.WA | Poland | $327M | -7% | -6% | 3% | 10.2× | 16.1% | +4.1% |
| Aekyung Chemical 161000.KS | South Korea | $326M | -41% | +3% | 2% | n/a | n/a | n/a |
| Anhui Annada Titanium Industry 002136.SZ | China | $327M | -33% | +12% | 2% | n/a | n/a | n/a |
| Chung Hwa Chemical Industrial Works 1727.TW | Taiwan | $325M | -4% | +5% | 5% | n/a | n/a | n/a |
| Guangdong Quanwei Technology 300716.SZ | China | $331M | +2% | +47% | -333% | n/a | n/a | n/a |
| Stella Chemifa 4109.T | Japan | $332M | -22% | +4% | 12% | 14.7× | 6.5% | +2.3% |
| Jiangsu HSC New Energy Materials 688353.SS | China | $332M | -35% | +153% | 39% | 12.9× | n/a | n/a |
| Weifang Yaxing Chemical 600319.SS | China | $320M | -32% | -5% | -10% | n/a | n/a | n/a |
| Trualt Bioenergy TRUALT.NS | India | $320M | -26% | -5% | 14% | 10.4× | n/a | n/a |
| Jiangmen Kanhoo Industry 300340.SZ | China | $318M | -31% | +20% | -7% | n/a | 51.6% | +4.7% |
| Longxing Technology 002442.SZ | China | $335M | -27% | +7% | 1% | n/a | n/a | n/a |
| Tomoe Engineering 6309.T | Japan | $336M | +3% | +2% | 9% | 12.4× | n/a | n/a |
| Zhejiang Wanfeng Chemical 603172.SS | China | $338M | -22% | +17% | 11% | n/a | n/a | n/a |
| Yangfan New Materials (Zhejiang) 300637.SZ | China | $314M | -19% | +3% | 1% | n/a | 57.5% | +13.4% |
| Suzhou Fushilai Pharmaceutical 301258.SZ | China | $313M | -21% | -15% | -13% | n/a | n/a | n/a |
| Gevo GEVO | United States | $344M | -24% | +121% | -30% | 30.2× | n/a | n/a |
| Styrenix Performance Materials STYRENIX.NS | India | $345M | -20% | +10% | 9% | 11.9× | 17.4% | +16.1% |
| Kiri Industries KIRIINDUS.NS | India | $345M | +16% | +11% | -25% | n/a | n/a | n/a |
| Toyo Gosei 4970.T | Japan | $346M | -55% | +16% | 12% | 12.2× | 15.9% | +9.1% |
| Wuxi Acryl Technology 603722.SS | China | $346M | -37% | +34% | -15% | 64.7× | n/a | n/a |
| Shenzhen Tongyi Industry 300538.SZ | China | $307M | -31% | -16% | -2% | n/a | n/a | n/a |